Wednesday, July 8, 2026

pharma · Urothelial Carcinoma Bladder · Castration Resistant Metastatic Prostate Cancer · AKTS

Aktis Oncology

Aktis Oncology clinical programs — 0 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Cambridge, USA HQ
90 Employees
Public company Type
AKTS · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Employees
90
Programs
2
Drugs
0
Patents
1
Intelligence · Clinical Programs

Aktis Oncology projects

0 ClinicalTrials.gov programs sponsored by Aktis Oncology.

Aktis Oncology has 0 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

No programs matched

Try a different phase filter or check back as we index more trials.

Frequently asked questions

How many clinical projects does Aktis Oncology have?

0 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.